HARVARD BIOSCIENCE INC — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-12-31

Reporting Person: Olson Kenneth Fletcher (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	F	3299	$4.29	Disposed	87137	Direct

Footnotes

F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on December 31, 2020.

F2: Includes (a) 27,567 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023; (b) 36,756 restricted stock units with performance based vesting conditions tied to relative total shareholder return that will vest on June 11, 2021, 2022 and 2023; (c) 10,057 remaining restricted stock units that will vest on November 1, 2021 and 2022; and (d) 12,757 shares of common stock beneficially owned by the Reporting Person (which includes 3,644 shares acquired under the Issuer's Employee Stock Purchase Plan).